Predictors of Outcome in Patients with Primary Achalasia Treated by Pneumatic Dilation.
- Author:
Sun Jin SYM
1
;
Hwoon Yong JUNG
;
Chang Lae JO
;
Hyung Suk JI
;
Tae Il PARK
;
Sa Rah PARK
;
Ah Young KIM
;
Seung Jae MYUNG
;
Jin Sok RYU
;
Suk Kyun YANG
;
Hyun Kwon HA
;
Weon Seon HONG
;
Jin Ho KIM
;
Young Il MIN
Author Information
1. Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. hyjung@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Achalasia;
Pneumatic dilation
- MeSH:
Barium;
Esophageal Achalasia*;
Follow-Up Studies;
Humans;
Manometry;
Radionuclide Imaging;
Recurrence
- From:Korean Journal of Gastrointestinal Endoscopy
2002;25(4):187-191
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Pneumatic dilation is the most effective non-surgical treatment option for the patients with achalasia. The aim of this study was to determine the predictors of outcome after pnematic dilation in patients with primary achalasia. METHODS: Thrity-five patients with primary achalasia between May 1996 and April 2001 were included. They were divided into two groups; responder and nonresponder. Esophageal manometry, scintigraphy and barium esophagogram was performed before dilation and 4 weeks after dilation. RESULTS: Seven patients having symptomatic relapse were treated with repeated pneumatic dilation. Remaining 28 patients (83%) had no recurrence during follow-up period (mean duration 16 month, range 6~43 month). Among the factors evaluated in the initial examination, only young age affected outcome (p=0.039). The post treatment retention fraction at 5, 20 minutes were the most valuable factors for predicting the clinical response (p<0.05). CONCLUSIONS: Older patients are more likely to have sustained response. Radionuclide esophageal emptying test remains a useful objective study evaluating esophageal transit before and after pneumatic dilation in the patients with achalasia and may have an important role in the follow-up evaluation of treatment for achalasia.